Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

News

Sygnature is proud of its many achievements, research collaborations and awards and delighted to publish these achievements wherever possible. Below you can read and hear about exciting new developments within the organization.

Filter by:

DMPK Drug Discovery News

Sygnature Discovery announces ambitious expansion plans with addition of Alderley Park facility

READ ARTICLE

News

Sygnature Discovery proves commitment to cyber security

READ ARTICLE

News

Sygnature Discovery appoints Dr Andy Black as Non-executive Chairman

READ ARTICLE

News

Sygnature Discovery raises over £2,700 for Parkinson’s UK

READ ARTICLE

News

Strategic Vision with the Appointment of Andy Lindstrom as Director of Marketing

READ ARTICLE

News

Sygnature Discovery focuses on US expansion with the Appointment of Dr Bill Marathias

READ ARTICLE

Blog DMPK Therapeutic Areas

Understanding and predicting brain penetration for CNS-targeted drugs

READ ARTICLE

News

British Toxicology Society Annual Meeting (Newcastle, 16-18 of April)

READ ARTICLE

Awards News

Discovery Building, Sygnature Discovery’s HQ, nominated for RICS Awards 2018, East Midlands

READ ARTICLE

Drug Discovery Therapeutic Areas

Sygnature Discovery’s medicinal chemists design improved agents against RSV infection

READ ARTICLE

News

Sygnature Discovery to co-host Predictive Toxicology in Discovery DMPK conference

READ ARTICLE

Events News

Sygnature Discovery team in the final of the 5th National RSC/SCI Retrosynthesis Competition

READ ARTICLE
MORE...

Upcoming Events

View All
2-6 Sep 2018

XXV EFMC International…

SLOVENIA

VISIT WEBSITE
30-01 Apr-May 2019

BioTrinity 2019

London, UK

VISIT WEBSITE
25-28 Sep 2018

Discovery on Target

Boston, USA

VISIT WEBSITE